PACI, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 519
EU - Europa 151
AS - Asia 91
OC - Oceania 1
Totale 762
Nazione #
US - Stati Uniti d'America 519
GB - Regno Unito 62
SG - Singapore 37
CN - Cina 27
SE - Svezia 25
IT - Italia 24
DE - Germania 17
HK - Hong Kong 10
TR - Turchia 10
UA - Ucraina 9
BG - Bulgaria 5
FI - Finlandia 3
BE - Belgio 2
FR - Francia 2
MY - Malesia 2
VN - Vietnam 2
ID - Indonesia 1
IN - India 1
KZ - Kazakistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 762
Città #
Fairfield 84
Santa Clara 56
Ashburn 55
Southend 44
Cambridge 32
Chandler 31
Singapore 31
Seattle 29
Woodbridge 29
Wilmington 25
Houston 21
Dearborn 20
Nyköping 20
Ann Arbor 19
Jacksonville 16
Modena 9
San Diego 9
Hong Kong 8
Izmir 8
Beijing 7
Princeton 5
Sofia 5
Bremen 4
Eugene 4
Falls Church 4
New York 4
Hounslow 3
Milan 3
Augusta 2
Brussels 2
Chiswick 2
Dong Ket 2
Indiana 2
London 2
Nanjing 2
Parma 2
Redmond 2
Shanghai 2
Belgrade 1
Bindlach 1
Bologna 1
Cheyenne 1
Chicago 1
Frankfurt am Main 1
Gambettola 1
Guangzhou 1
Helsinki 1
Jakarta 1
Kilburn 1
Kokshetau 1
Leawood 1
Monmouth Junction 1
Nagpur 1
Nutley 1
Phoenix 1
Redwood City 1
Reggio Emilia 1
Reggio Nell'emilia 1
San Antonio 1
Southwark 1
Verona 1
Washington 1
Totale 629
Nome #
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. 208
PUREAIR protocol: Randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancer 157
Placental transmogrification of the lung: Clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells 155
Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma 126
Rehabilitation for lung cancer patients undergoing surgery: results of the PUREAIR randomized trial 62
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 17
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer: insights into mitochondrial modulation 16
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 13
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 11
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 11
Totale 776
Categoria #
all - tutte 4.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 0 19 28 29 18 18 4 10 3
2020/2021106 12 3 9 7 16 6 4 16 5 14 7 7
2021/2022107 0 13 9 2 3 10 6 8 13 8 29 6
2022/2023100 16 9 8 5 12 16 6 9 12 0 1 6
2023/202464 3 7 2 8 16 9 2 5 0 3 2 7
2024/2025122 7 16 17 31 51 0 0 0 0 0 0 0
Totale 776